Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25278-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- PRTN3 antibody
- Antibody type
- Polyclonal
- Description
- PRTN3 antibody (Cat. #25278-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat.
Cathepsin C-driven enhancement of neutrophil extracellular trap formation contributes to acute lung injury.
Meningitic Escherichia coli-Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis.
Activation of inflammasomes by tyrosine kinase inhibitors of vascular endothelial growth factor receptor: Implications for VEGFR TKIs-induced immune related adverse events.
Comparative Proteomic Analysis of tPVAT during Ang II Infusion.
Zheng C, Chen L, Lv X, He Y, Hu X, Ding Y, Wang S, Wei P, Zhang T, Zhang H, Zhang X, Zhang Y
Journal of ovarian research 2025 Sep 29;18(1):211
Journal of ovarian research 2025 Sep 29;18(1):211
Cathepsin C-driven enhancement of neutrophil extracellular trap formation contributes to acute lung injury.
Wu X, Liu H, Qin Q, Yuan L, Yao Y, Du X, Qin Q, Wang L, Zhao Q, Qin L, Xiang Y, Yang M, Qin X, Liu C
iScience 2025 Dec 19;28(12):113928
iScience 2025 Dec 19;28(12):113928
Meningitic Escherichia coli-Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis.
Xu B, Chen J, Fu J, Yang R, Yang B, Huo D, Tan C, Chen H, Wang X
Frontiers in cellular neuroscience 2022;16:814867
Frontiers in cellular neuroscience 2022;16:814867
Activation of inflammasomes by tyrosine kinase inhibitors of vascular endothelial growth factor receptor: Implications for VEGFR TKIs-induced immune related adverse events.
Imano H, Kato R, Ijiri Y, Hayashi T
Toxicology in vitro : an international journal published in association with BIBRA 2021 Mar;71:105063
Toxicology in vitro : an international journal published in association with BIBRA 2021 Mar;71:105063
Comparative Proteomic Analysis of tPVAT during Ang II Infusion.
Liang X, Guan H, Sun J, Qi Y, Yao W
Biomedicines 2021 Dec 2;9(12)
Biomedicines 2021 Dec 2;9(12)
No comments: Submit comment
No validations: Submit validation data